Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has a strategic collaboration with Sensorion to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.
Industry, Sector and Symbol
Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolASX:COH
CUSIPN/A
Phone+61-2-94286555
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins17.90%
Return on Equity41.48%
Return on Assets19.99%
Miscellaneous
EmployeesN/A
Outstanding Shares57,430,000
Market Cap$11.06 billion
Cochlear (ASX:COH) Frequently Asked Questions
What is Cochlear's stock symbol?
Cochlear trades on the ASX under the ticker symbol "COH."
Who are some of Cochlear's key competitors?
Some companies that are related to Cochlear include GN Store Nord A/S (GGNDF), ConvaTec Group (CTEC), Draegerwerk AG & Co KGaA Preference Shares (DRW3), Stratec Biomedical (SBS), REVA Medical (RVA), Medica Group (MGP), Ellex Medical Lasers (ELXMF), Creo Medical Group (CREO), Hamilton Thorne (HTL), Kromek Group (KMK), Electromed (ELMD), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Protech Home Medical (PHM) and MRI Interventions (MRIC).
Who are Cochlear's key executives?
Cochlear's management team includes the folowing people:
- Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 50)
- Mr. Brent Andrew Cubis BComm, CA, Chief Financial Officer
- Mr. Jan Janssen MSc Elec Eng, Chief Technology Officer
- Mr. Richard Brook, Pres of EMEA & Latin American Region
- Mr. Anthony Manna, Pres of Americas Region
What is Cochlear's stock price today?
One share of COH stock can currently be purchased for approximately A$201.64.
How big of a company is Cochlear?
Cochlear has a market capitalization of $11.06 billion.
What is Cochlear's official website?
How can I contact Cochlear?
Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.
MarketBeat Community Rating for Cochlear (ASX COH)
MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote "Outperform" if you believe COH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days.
